Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosisTung‐Wei Hsu(Taipei Medical University-Shuang Ho Hospital), Shing‐Chuan Shen(Taipei Medical University)AgingJuly 11, 202310.18632/aging.204867Cited by 14SaveCiteExport RISWatch citationsRelated PapersFOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma|Cancer & Metabolism|2025|1